Aortopathy pathophysiology features in patients with bicuspid aortic valve.

Особенности патофизиологии аортопатии у пациентов с двустворчатым аортальным клапаном
Arystan Seidalin 1, Turlybek Tuganbekov 2, Vladimir Dikolayev 2 3, Serik Aitaliyev 3
More Detail
1 «City Cardiological Center», department of Cardiac Surgery. Almaty, Kazakhstan
2 «Astana Medical University». department of Surgery. Astana, Kazakhstan
3 «National Scientific Medical Research Center». department of Cardiac Surgery. Astana, Kazakhstan
J CLIN MED KAZ, Volume 3, Issue 41, pp. 14-20. https://doi.org/10.23950/1812-2892-2016-3-14-20
OPEN ACCESS 4246 Views 3225 Downloads
Download Full Text (PDF)

ABSTRACT

This review is devoted to one of the vital topics in cardiovascular surgery – pathophysiologyof an aortopathy in case of bicuspid aortic valve. In the article reviewed the modern point of view on a problem considering new achievements in genetics, molecular biology and altered haemodynamic.
Keywords: aortic aneurysm, bicuspid aortic valve, metalloproteinase

CITATION

Seidalin A, Tuganbekov T, Dikolayev V, Aitaliyev S. Aortopathy pathophysiology features in patients with bicuspid aortic valve.. Journal of Clinical Medicine of Kazakhstan. 2016;3(41):14-20. https://doi.org/10.23950/1812-2892-2016-3-14-20

REFERENCES

  • Alan C. Braveman, Hasan Güven, Michael A. Beardslee et al. The bicuspid valve// Current Problem in Cardiology.-2005 Sep.- 30(9). - P. 470-522.
  • Michelena HI., Khanna AD., Mahoney D. et al. Incidence of aortic complications in patients with bicuspid aortic valves// JAMA.-2011.-396.-P.1890-900.
  • Choudhury N., Bouchot O., Rouleau L. et al. Local mechanical and structural properties of healthy and diseased human ascending aorta tissue// Cardiovascular Pathology.-2009.-18.-P.83-91.
  • Elefteriades JA. Indications for aortic replacement// J. Thoracic cardiovascular surgery.-2010.-140.-6S.-P.5-9
  • Couzin-Frenkel J. Medicine, frightening risk of Marfan syndrome, and potential treatment, elucidated// Science.-2011.- 332.-P.297
  • Davies RR.,Gallo A., Coady MA. et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms// Ann. Thorac. Surg.-2006.-81.-P. 169-77.
  • Kirsch EWM, Radu NC., Allaire E., Loisance DY. Pathobiology of idiopathic ascending aortic aneurysms//Asian Cardiovascular Thorac. Ann.-2006.-14.-P.254-260.
  • Pathophysiology of heart disease.// Lilly LS. 2nd edition, Baltimor, Md: Lippincott Williams&Wilkins.-1997
  • Agmon Y., Khandheria BK., Meissner i. et al. Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation// J. Am. Coll. Cardiol.-2003.-42.-P.1076-1083.
  • Kappetein AP., Gittenberger-de Groot AC., Zwinderman AH. et al. The neural crest as a possible pathogeneticfactor incoarctation of the aorta and bicuspid aortic valve// J. Thoracic Cardiovascular Surg.-1991.-102.-P.830-836.
  • Bonderman D., Gharehbaghi-Schnell E., Wollenek G. et.al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation// Circulation.-1999.- 99.-P. 2138–2143
  • De Sa M., Moshkovitz Y., Butany J., David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure//J.Thorac.Cardiovasc. Surg.- 1999.-118.- P. 588–596.
  • Niwa K., Perloff JK., Bhuta SM. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses//Circulation.-2001.- 103.-P. 393–400.
  • Becker AE., Becker MJ., Edwards JE. Anomalies associated with coarctation of aorta particular reference to infancy// Circulation.- 1970.- 41.-P. 1067–1075
  • Korpal-Szczyrska M., Aleszewicz-Baranowska J., Dorant B. et al. Cardiovascular malformations in Turner syndrome [in Polish]//EndokrynolDiabetolChorPrzemianyMateriiWiekuRozw.- 2005.- 11.-P. 211–214.
  • Glick BN., Roberts WC. Congenitally bicuspid aortic valve in multiply family members// Ann. J. Cardiol.-1994.-73.-73.- P.400-404.
  • Huntington K., Hunter A., Chan KA. Prospective study to assess the frequency offamilial clustering of congenital bicuspid aortic valve// J Am CollCardiol.- 1997.-30. P. 1809-12.
  • Cripe L, Andelfinger G, Martin LJ, et al. Bicuspid aortic valve is heritable// J AmCollCardiol.- 2004.-44.- P. 138-43.
  • Huntington K., Hunter AG., Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve// J Am CollCardiol.- 1997.- 30 P. 1809–1812
  • Clementi M., Notari L., Borghi A., Tenconi R. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance// Am J Med Genet.- 1996.- 62.-P. 336–338
  • Miller MJ., Geffner ME., Lippe BM et al. Echocardiography reveals a high incidence of bicuspid aortic valve in Turner syndrome// J Pediatr. 1983.- 102.-P. 47–50.
  • Martin LJ., Ramachandran V., Cripe LH. et al. Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations// Hum Genet.- 2007.- 121.- P. 275–284 
  • Garg V., Muth AN., Ransom JF et al. Mutations in NOTCH1 cause aortic valve disease.// Nature.- 2005.- 437.- P. 270–274
  • Mohamed SA., Aherrahrou Z., Liptau H. et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve//BiochemBiophys Res Commun.- 2006.- 345.- P. 1460–1465.
  • Kodo K, Nishizawa T, Furutani M, et al. GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling// Proceedings of the National Academy of Sciences of the United States of America.- 2009.- 106(33).- P.13933–13938.
  • Maitra M, Koenig SN, Srivastava D, Garg V. Identification of GATA6 sequence variants in patients with congenital heart defects// Pediatric Research.- 2010.-68(4).-P.281–285.
  • Lepore JJ, Mericko PA, Cheng L, Lu MM, Morrisey EE, Parmacek MS. GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis// Journal of Clinical Investigation.- 2006.-116(4).- P.929–939.
  • Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene// Nature.- 1991.-352(6333).-P.337–339.
  • Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders// Human Molecular Genetics.- 1995.-4.-P.1799–1809.
  • Robinson PN, Booms P, Katzke S, et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies// Human Mutation.- 2002.-20(3).-P.153–161.
  • Fedak PWM, De Sa MPL, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation// Journal of Thoracic and Cardiovascular Surgery.- 2003.-126(3).P. 797–805.
  • Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies// J Med Genet.- 2000.- 37.P. 9–25.
  • Ben-Shachar S., Ou Z., Shaw CA. et al. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome// Am J Hum Genet.- 2008.- 82.-P. 214–221.
  • Guo DC., Pannu H., Tran-Fadulu V. et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections// Nat Genet.- 2007.- 39.- P. 1488–1493.
  • Tischfield MA, Bosley TM, Salih MAM. et al. Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development// Nature Genetics.- 2005.-37(10).-P.1035–1037.
  • Andelfinger G, Tapper AR, Welch RC. et al. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes// American Journal of Human Genetics.- 2002.-71(3).- P.663–668.
  • Lee TC, Zhao YD, Courtman DW, Stewart DJ. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase// Circulation.- 2000.- 101.- P. 2345–2348.
  • Salah A. Mohamed, Arlo Radtke, RozaSaraei et al. Locally different endothelial Nitric Oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve// Cardiology research and practice.- 2012.
  • Aicher D, Urbich C, Zeiher A, Dimmeler S, Schafers HJ. Endothelial nitric oxide synthase in bicuspid aortic valve disease// Ann Thorac Surg.- 2007.- 83.- P. 1290–1294.
  • Gsell O. Wandnekrosen der aorta als selbstandige Erkrankung und ihre Beziehung zur spontanruptur.//Virchow Archiv.- 1928.- 270.-P. 1–36.
  • Erdheim J. Medionecrosisaortaeidiopathica// Virchows Arch.- 1929.- 273.-P. 454–479
  • Morrison-Graham K, Schatteman GC, Bork T, Bowen-Pope DF, Weston JA. A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells// Development.- 1992.- 115.-P. 133–142.
  • Niwa K., PerloffJK.,Bhuta SM. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses// Circulation.- 2001.- 103.- P. 393–400.
  • Bauer M., Pasic M., Meyer R. et al. Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve// Ann Thorac Surg.- 2002.- 74.-P. 58–62.
  • Collins MJ, Dev V, Strauss BH, Fedak PW, Butany J. Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases// J ClinPathol.- 2008.- 61.-P. 519–523.
  • Tang PCY, Coady MA, Lovoulos C. et. Al. Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms// Circulation.- 2005.- 112.-P. 1098–1105.
  • Della Corte A., Quarto C., Bancone C. et al. Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling// J .ThoracCardiovasc Surg.- 2008.- 135.- P. 8–18.
  • Cotrufo M, Della Corte A, De Santo LS.et al. Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: preliminary results// J.ThoracCardiovasc Surg.- 2005.- 130.- P. e501–e504.
  • Nataatmadja M, West M, West J. et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm// Circulation.- 2003.- 108.- P. II329–II334
  • Schmid F-X, Bielenberg K, Schneider A. et al. Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins//Eur J Cardiothorac Surg.- 2003.- 23.-P. 537–543.
  • Boyum J., Fellinger EK., Schmoker JD. et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves// J. ThoracCardiovasc Surg. 2004.- 127.- P. 686–691.
  • Wilton E, Jahangiri M. Post-stenotic aortic dilatation// J.Cardiothorac Surg.- 2006.- 1.-P.7.
  • DolleryCM., McEwan JR., Henney AM. Matrix metalloproteinases and cardiovascular disease//Circ Res.- 1995.- 77.-P. 863–868. 
  • Jones JA., Stroud RE., Kaplan BS. et al. Differential protein kinase C isoform abundance in ascending aortic aneurysms from patients with bicuspid versus tricuspid aortic valves// Circulation.- 2007.- 116.- P. 144–149.
  • Ikonomidis JS., Jones JA., Barbour JR et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves// J ThoracCardiovasc Surg.- 2007.- 133.- P. 1028–1036.
  • Simon W. Rabkin. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm – comparison with and without bicuspid aortic valve: a meta-analysis// Vasa.-2014.-43.- P. 433-442.
  • Novaro GM., Tiong IY., Pearce GL et al. Features and predictors of ascending aortic dilatation in association with a congenital bicuspid aortic valve// Am J Cardiol.- 2003.- 92.- P. 99–101.
  • Lehoux S, Tedgui A. Cellular mechanics and gene expression in blood vessels// J Biomech.- 2003.- 36.- P. 631–643.
  • Robicsek F., ThubrikarMJ., Cook JW., Fowler B. The congenitally bicuspid aortic valve: how does it function? Why does it fail?// Ann Thorac Surg.- 2004.- 77.- P. 177–185.
  • Keane MG., Wiegers SE., Plappert T. et al. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions// Circulation.- 2000.- 102.- P. III35–III39.
  • Novaro GM., Tiong IY., Pearce GL. Features and predictors of ascending aortic dilatation in association with a congenital bicuspid aortic valve// Am J Cardiol.- 2003.- 92.- P. 99–101.
  • Bauer M, Siniawski H, Pasic M, Schaumann B, Hetzer R. Different hemodynamic stress of the ascending aorta wall in patients with bicuspid and tricuspid aortic valve// J Card Surg.- 2006.- 21.-P.218–220.
  • Della Corte A., Bancone C., Quarto C. Predictors of ascending aortic dilatation with bicuspid aortic valve: a wide spectrum of disease expression//Eur J Cardiothorac Surg.- 2007.- 31.-P. 397–404.
  • Linhartova K., Beranek V., Sefrna F. et al. Aortic stenosis severity is not a risk factor for poststenotic dilatation of the ascending aorta//Circ J.- 2007.- 71.- P. 84–88.
  • Girdauskas E., Borger MA.,Secknus MA., Girdauskas G., Kuntze T. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument//Eur J Cardiothorac Surg.- 2011.- 39(6).- P. 809-14.
  • Pasta S., Rinaudo A., Luca A. Difference in hemodynamic and wall stress of ascending thoracic aortic aneurysms with bicuspid and tricuspid aortic valve//J Biomech.- 2013.-46(10).- P. 1729-38.
  • Wilton E., Bland M., Thompson M., Jahangiri M.Matrix metalloproteinase expression in the ascending aorta and aortic valve// Interact.Cardiovasc.Thorac. Surg.- 2008.-7(1).- P. 37-40